Literature DB >> 33900499

Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.

Takahiro Mimae1, Hisashi Saji2, Hiroshige Nakamura3, Norihito Okumura4, Masanori Tsuchida5, Makoto Sonobe6, Takuro Miyazaki7, Keiju Aokage8, Masayuki Nakao9, Tomohiro Haruki3, Morihito Okada1,10, Kenji Suzuki10,11, Masayuki Chida12,13.   

Abstract

BACKGROUND: Anatomic resection with lymph node dissection or sampling is the standard treatment for early non-small cell lung cancer (NSCLC), and wedge resection is an option for compromised patients. This study aimed to determine whether wedge resection can provide comparable prognoses for elderly patients with NSCLC.
METHODS: The study analyzed the clinicopathologic findings and surgical outcomes during a median follow-up period of 39.6 months for 156 patients with solid dominant (consolidation-to-tumor ratio > 0.5) small (whole tumor size ≤ 2 cm) NSCLC among 892 patients 80 years of age or older with medically operable lung cancer between April 2015 and December 2016.
RESULTS: The 3-year overall survival (OS) rates after wedge resection and after segmentectomy plus lobectomy did not differ significantly (86.5 %; 95 % confidence interval [CI], 74.6-93.0 % vs 83.7 % 95 % CI, 74.0-90.0 %; P = 0.92). Multivariable Cox regression analysis of OS with propensity scores showed that the surgical procedure was not an independent prognostic predictor (hazard ratio [HR], 0.84; 95 % CI, 0.39-1.8; P = 0.64). The 3-year OS rates were slightly better after wedge resection for 97 patients who could tolerate lobectomy than after segmentectomy plus lobectomy (89.4 %; 95 % CI, 73.8-95.9 % vs 75.8 %; 95 % CI, 62.0-85.2 %; P = 0.14). The cumulative incidence of other causes for death was marginally higher after segmentectomy plus lobectomy than after wedge resection (P = 0.079).
CONCLUSIONS: Wedge resection might be equivalent to lobectomy or segmentectomy for selected patients 80 years of age or older with early-stage NSCLC who can tolerate lobectomy.

Entities:  

Year:  2021        PMID: 33900499     DOI: 10.1245/s10434-021-09835-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm.

Authors:  Xi Lei; Ning Zhou; Hao Zhang; Tong Li; Fan Ren; Bo Zhang; Xiongfei Li; Lingling Zu; Zuoqing Song; Song Xu
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

2.  Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function.

Authors:  Takahiro Mimae; Yoshihiro Miyata; Takashi Kumada; Yoshinori Handa; Yasuhiro Tsutani; Morihito Okada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.